---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-24-013382"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:25:13.946448+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro regains Nasdaq bid price compliance; MVLS deficiency still pending

## Summary
- Nasdaq notified Alzamend on July 30, 2024 that bid price compliance is regained after 10 consecutive days above $1.00.
- Minimum Bid Price Requirement was met on July 29, 2024; matter is now closed.
- MVLS deficiency remains: Alzamend must demonstrate compliance with $2.5M stockholder equity by September 23, 2024.
- Company appealed delisting for MVLS; hearing panel granted extension to Sept 23, 2024.

## SEC filing metadata
- accession: 0001214659-24-013382
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465924013382/0001214659-24-013382-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465924013382/o7302498k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-24-013382
- JSON: https://secwatch.observer/filing/0001214659-24-013382.json
- Plain text: https://secwatch.observer/filing/0001214659-24-013382.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.